

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.55301932 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.55301932 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.04517950 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.04225048 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.94334502 |
| 6 | protein maturation by protein folding (GO:0022417) | 3.92027599 |
| 7 | neuronal action potential propagation (GO:0019227) | 3.72918905 |
| 8 | regulation of synaptic vesicle transport (GO:1902803) | 3.70388528 |
| 9 | signal peptide processing (GO:0006465) | 3.68529933 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.65902036 |
| 11 | presynaptic membrane assembly (GO:0097105) | 3.65056168 |
| 12 | presynaptic membrane organization (GO:0097090) | 3.51763120 |
| 13 | detection of calcium ion (GO:0005513) | 3.48724005 |
| 14 | peptide hormone processing (GO:0016486) | 3.47469977 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 3.42279744 |
| 16 | postsynaptic membrane organization (GO:0001941) | 3.37316414 |
| 17 | synaptic vesicle maturation (GO:0016188) | 3.36137878 |
| 18 | endocrine pancreas development (GO:0031018) | 3.34438263 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 3.28892494 |
| 20 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.27490749 |
| 21 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16675333 |
| 22 | glutamate secretion (GO:0014047) | 3.09430420 |
| 23 | insulin secretion (GO:0030073) | 3.09014497 |
| 24 | amino sugar catabolic process (GO:0046348) | 3.08753743 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.04814197 |
| 26 | locomotory exploration behavior (GO:0035641) | 3.03951031 |
| 27 | neuromuscular process controlling posture (GO:0050884) | 3.02602840 |
| 28 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.00410103 |
| 29 | protein retention in ER lumen (GO:0006621) | 2.99786329 |
| 30 | neurotransmitter secretion (GO:0007269) | 2.98809666 |
| 31 | magnesium ion transport (GO:0015693) | 2.96319207 |
| 32 | virion attachment to host cell (GO:0019062) | 2.96274423 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 2.96274423 |
| 34 | positive regulation of insulin secretion (GO:0032024) | 2.91178441 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90161505 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89759486 |
| 37 | negative regulation of cell killing (GO:0031342) | 2.89759486 |
| 38 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.88511511 |
| 39 | negative regulation of mast cell activation (GO:0033004) | 2.87832895 |
| 40 | negative regulation of catecholamine secretion (GO:0033604) | 2.87648371 |
| 41 | synaptic transmission, glutamatergic (GO:0035249) | 2.86910575 |
| 42 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.86211920 |
| 43 | regulation of vesicle fusion (GO:0031338) | 2.85657533 |
| 44 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.84927975 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 2.84599229 |
| 46 | regulation of insulin secretion (GO:0050796) | 2.84057697 |
| 47 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.83747789 |
| 48 | glandular epithelial cell differentiation (GO:0002067) | 2.83686541 |
| 49 | cerebellar Purkinje cell layer development (GO:0021680) | 2.80347999 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.79195070 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 2.79140386 |
| 52 | ER overload response (GO:0006983) | 2.79130061 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 2.79038406 |
| 54 | positive regulation of membrane potential (GO:0045838) | 2.78657196 |
| 55 | regulation of autophagic vacuole assembly (GO:2000785) | 2.76534757 |
| 56 | response to peptidoglycan (GO:0032494) | 2.76006764 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.73734006 |
| 58 | response to pheromone (GO:0019236) | 2.73237659 |
| 59 | regulation of beta-amyloid formation (GO:1902003) | 2.72871621 |
| 60 | positive regulation of exocytosis (GO:0045921) | 2.72522524 |
| 61 | long-term synaptic potentiation (GO:0060291) | 2.72401395 |
| 62 | regulation of glucocorticoid secretion (GO:2000849) | 2.72212428 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 2.71097492 |
| 64 | positive regulation of amino acid transport (GO:0051957) | 2.69796325 |
| 65 | microglial cell activation (GO:0001774) | 2.68805368 |
| 66 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.68579818 |
| 67 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68020266 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 2.67720420 |
| 69 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.66992129 |
| 70 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.65919631 |
| 71 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.65919631 |
| 72 | positive regulation of heat generation (GO:0031652) | 2.65605410 |
| 73 | negative regulation of norepinephrine secretion (GO:0010700) | 2.65037937 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.64905654 |
| 75 | response to dietary excess (GO:0002021) | 2.64878340 |
| 76 | axon ensheathment in central nervous system (GO:0032291) | 2.64747622 |
| 77 | central nervous system myelination (GO:0022010) | 2.64747622 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64110136 |
| 79 | transferrin transport (GO:0033572) | 2.63116696 |
| 80 | reactive oxygen species biosynthetic process (GO:1903409) | 2.63062330 |
| 81 | protein localization to synapse (GO:0035418) | 2.62358908 |
| 82 | lytic vacuole organization (GO:0080171) | 2.62097085 |
| 83 | lysosome organization (GO:0007040) | 2.62097085 |
| 84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.61996817 |
| 85 | ceramide catabolic process (GO:0046514) | 2.61978252 |
| 86 | regulation of dopamine metabolic process (GO:0042053) | 2.61737375 |
| 87 | regulation of catecholamine metabolic process (GO:0042069) | 2.61737375 |
| 88 | regulation of peptide hormone secretion (GO:0090276) | 2.61669636 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.61574960 |
| 90 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.61408021 |
| 91 | regulation of peptide secretion (GO:0002791) | 2.59749769 |
| 92 | neurotransmitter transport (GO:0006836) | 2.58907296 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.58432394 |
| 94 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.57839125 |
| 95 | cellular response to glucagon stimulus (GO:0071377) | 2.57534750 |
| 96 | adhesion of symbiont to host (GO:0044406) | 2.56305694 |
| 97 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.54817188 |
| 98 | positive regulation of mast cell degranulation (GO:0043306) | 2.54817188 |
| 99 | regulation of neurotransmitter secretion (GO:0046928) | 2.54178394 |
| 100 | N-acetylneuraminate metabolic process (GO:0006054) | 2.54019915 |
| 101 | long-term memory (GO:0007616) | 2.53491014 |
| 102 | glycosphingolipid catabolic process (GO:0046479) | 2.50871998 |
| 103 | chemosensory behavior (GO:0007635) | 2.50525126 |
| 104 | intraciliary transport (GO:0042073) | 2.48929198 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.48805853 |
| 106 | regulation of mast cell activation (GO:0033003) | 2.48443572 |
| 107 | regulation of norepinephrine secretion (GO:0014061) | 2.48108481 |
| 108 | negative regulation of neurotransmitter transport (GO:0051589) | 2.48081950 |
| 109 | glutamate receptor signaling pathway (GO:0007215) | 2.47207620 |
| 110 | ferric iron transport (GO:0015682) | 2.47007002 |
| 111 | trivalent inorganic cation transport (GO:0072512) | 2.47007002 |
| 112 | T-helper 1 type immune response (GO:0042088) | 2.46559852 |
| 113 | positive regulation of mast cell activation (GO:0033005) | 2.45777818 |
| 114 | regulation of exocytosis (GO:0017157) | 2.45635070 |
| 115 | transmission of nerve impulse (GO:0019226) | 2.45484479 |
| 116 | startle response (GO:0001964) | 2.45272502 |
| 117 | establishment of synaptic vesicle localization (GO:0097480) | 2.45134528 |
| 118 | synaptic vesicle transport (GO:0048489) | 2.45134528 |
| 119 | positive regulation of cholesterol efflux (GO:0010875) | 2.45115492 |
| 120 | positive regulation of peptide secretion (GO:0002793) | 2.45085497 |
| 121 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.44228540 |
| 122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.44059223 |
| 123 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.43721402 |
| 124 | positive regulation of peptide hormone secretion (GO:0090277) | 2.43162089 |
| 125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.43135972 |
| 126 | response to redox state (GO:0051775) | 2.43004706 |
| 127 | regulation of cholesterol storage (GO:0010885) | 2.42527412 |
| 128 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.42026083 |
| 129 | synaptic vesicle endocytosis (GO:0048488) | 2.41667479 |
| 130 | female mating behavior (GO:0060180) | 2.41646391 |
| 131 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.40746829 |
| 132 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.40550872 |
| 133 | regulation of oxidative phosphorylation (GO:0002082) | 2.40413232 |
| 134 | regulation of heat generation (GO:0031650) | 2.40175555 |
| 135 | regulation of chemokine biosynthetic process (GO:0045073) | 2.40008549 |
| 136 | phagosome maturation (GO:0090382) | 2.39968846 |
| 137 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.39894208 |
| 138 | mannosylation (GO:0097502) | 2.39721401 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38803609 |
| 140 | vocalization behavior (GO:0071625) | 2.38723538 |
| 141 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.38371393 |
| 142 | positive regulation of prostaglandin secretion (GO:0032308) | 2.38086091 |
| 143 | dopamine biosynthetic process (GO:0042416) | 2.38047411 |
| 144 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.37956091 |
| 145 | macrophage activation (GO:0042116) | 2.35148846 |
| 146 | regulation of fever generation (GO:0031620) | 2.34636579 |
| 147 | oligosaccharide catabolic process (GO:0009313) | 2.32482253 |
| 148 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.32408856 |
| 149 | NIK/NF-kappaB signaling (GO:0038061) | 2.32386292 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.31938534 |
| 151 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.30664702 |
| 152 | autophagic vacuole fusion (GO:0000046) | 2.28150318 |
| 153 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.27935591 |
| 154 | mature B cell differentiation involved in immune response (GO:0002313) | 2.27301180 |
| 155 | indole-containing compound catabolic process (GO:0042436) | 2.27110129 |
| 156 | indolalkylamine catabolic process (GO:0046218) | 2.27110129 |
| 157 | tryptophan catabolic process (GO:0006569) | 2.27110129 |
| 158 | glycolipid catabolic process (GO:0019377) | 2.26753347 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.26420645 |
| 160 | positive regulation of fatty acid transport (GO:2000193) | 2.26257014 |
| 161 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.25359788 |
| 162 | granulocyte activation (GO:0036230) | 2.24794303 |
| 163 | positive regulation of cholesterol transport (GO:0032376) | 2.24503398 |
| 164 | positive regulation of sterol transport (GO:0032373) | 2.24503398 |
| 165 | response to protozoan (GO:0001562) | 2.22034393 |
| 166 | negative regulation of innate immune response (GO:0045824) | 2.21806050 |
| 167 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21729365 |
| 168 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.21562332 |
| 169 | negative regulation of interleukin-1 production (GO:0032692) | 2.21066754 |
| 170 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.19918492 |
| 171 | defense response to protozoan (GO:0042832) | 2.19723891 |
| 172 | lymphocyte chemotaxis (GO:0048247) | 2.18566780 |
| 173 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.17156444 |
| 174 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.16774565 |
| 175 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.15892936 |
| 176 | regulation of leukocyte degranulation (GO:0043300) | 2.15199737 |
| 177 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.15106799 |
| 178 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.14905243 |
| 179 | macrophage chemotaxis (GO:0048246) | 2.13349280 |
| 180 | monocyte chemotaxis (GO:0002548) | 2.12957354 |
| 181 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12397957 |
| 182 | modulation by symbiont of host defense response (GO:0052031) | 2.12397957 |
| 183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12397957 |
| 184 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12397957 |
| 185 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12397957 |
| 186 | modulation by symbiont of host immune response (GO:0052553) | 2.12397957 |
| 187 | response to pH (GO:0009268) | 2.10894702 |
| 188 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.10685404 |
| 189 | regulation of macrophage chemotaxis (GO:0010758) | 2.09782605 |
| 190 | positive regulation of icosanoid secretion (GO:0032305) | 2.08392675 |
| 191 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.07703044 |
| 192 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.07301150 |
| 193 | superoxide anion generation (GO:0042554) | 2.06076845 |
| 194 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.05944555 |
| 195 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.05286709 |
| 196 | negative regulation of interleukin-6 production (GO:0032715) | 2.04022038 |
| 197 | sphingolipid catabolic process (GO:0030149) | 2.03621180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.01608851 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26781825 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20608972 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00394035 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89053195 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69845710 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65064640 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59959514 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.38914273 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36076900 |
| 11 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.34174130 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22077134 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.20192697 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17775440 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.16795301 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15173767 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13949203 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13480888 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13020741 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.07049498 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03662748 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03425153 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.01128764 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.99457015 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.98930955 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97380927 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95531854 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90668565 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89985987 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86672502 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85086178 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83638869 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83638869 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83272481 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79804950 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75214711 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75071945 |
| 38 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.74769374 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.73953612 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73933012 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72446767 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69993436 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67648812 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65569034 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65450326 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63018452 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62173549 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61357196 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53817829 |
| 50 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51580163 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51500458 |
| 52 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.50575175 |
| 53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.49330002 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48939492 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48678269 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48210681 |
| 57 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.45798672 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44647343 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43659770 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.42508721 |
| 61 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41635282 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41445307 |
| 63 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.40845390 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40258956 |
| 65 | * P68_20966046_ChIP-Seq_HELA_Human | 1.38963739 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38873490 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38078039 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37415670 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36708786 |
| 70 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36011174 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33216994 |
| 72 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.32386597 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31961009 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31945874 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31047212 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30888245 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29498619 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26764447 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26364145 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25698248 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25588616 |
| 82 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25371448 |
| 83 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23582487 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23407420 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22942886 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22612136 |
| 87 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.19630326 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.18745873 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17796123 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16585941 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.16548164 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15533387 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15303743 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14975943 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14961861 |
| 96 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12799639 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12645601 |
| 98 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12300799 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12300658 |
| 100 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12139431 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11637171 |
| 102 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11208760 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10890108 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10620933 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10560119 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.09308907 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08771855 |
| 108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08370668 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06768943 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06713321 |
| 111 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.06054684 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05950789 |
| 113 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05636723 |
| 114 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05462351 |
| 115 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04904676 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04234811 |
| 117 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03001763 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01925267 |
| 119 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01224016 |
| 120 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01102749 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00933728 |
| 122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00831402 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00572491 |
| 124 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00399391 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99866318 |
| 126 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99751598 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99563130 |
| 128 | * P300_27268052_Chip-Seq_Bcells_Human | 0.99106684 |
| 129 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98868342 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98863375 |
| 131 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97774014 |
| 132 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97319004 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96328781 |
| 134 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.96250790 |
| 135 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.96071825 |
| 136 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.95727285 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95031941 |
| 138 | ERA_21632823_ChIP-Seq_H3396_Human | 0.94793360 |
| 139 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93266597 |
| 140 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93075822 |
| 141 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91893315 |
| 142 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91836981 |
| 143 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91754178 |
| 144 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91579790 |
| 145 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91066190 |
| 146 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90363881 |
| 147 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90092161 |
| 148 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89390355 |
| 149 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88971045 |
| 150 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88939809 |
| 151 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88692036 |
| 152 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87290335 |
| 153 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86293571 |
| 154 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85094045 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84182796 |
| 156 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83313161 |
| 157 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83204939 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83047388 |
| 159 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82062041 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80777983 |
| 161 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79472007 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78667409 |
| 163 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.78459259 |
| 164 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78432599 |
| 165 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78336928 |
| 166 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.78006190 |
| 167 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77976975 |
| 168 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77976975 |
| 169 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77966939 |
| 170 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77936198 |
| 171 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.77866412 |
| 172 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.76986244 |
| 173 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76759640 |
| 174 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76543635 |
| 175 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76429483 |
| 176 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.75541819 |
| 177 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.75351152 |
| 178 | AR_19668381_ChIP-Seq_PC3_Human | 0.74830092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 3.26352371 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.18327680 |
| 3 | MP0009840_abnormal_foam_cell | 3.15336954 |
| 4 | MP0003880_abnormal_central_pattern | 3.14048207 |
| 5 | MP0006082_CNS_inflammation | 3.00563718 |
| 6 | MP0010386_abnormal_urinary_bladder | 2.93464717 |
| 7 | MP0003303_peritoneal_inflammation | 2.85553679 |
| 8 | MP0003724_increased_susceptibility_to | 2.79356147 |
| 9 | MP0005646_abnormal_pituitary_gland | 2.76135998 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.72448865 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.70523856 |
| 12 | MP0003436_decreased_susceptibility_to | 2.70350639 |
| 13 | MP0004270_analgesia | 2.66147783 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.64526839 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.61248629 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.57069709 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.45527829 |
| 18 | MP0005671_abnormal_response_to | 2.36577853 |
| 19 | MP0009785_altered_susceptibility_to | 2.28845802 |
| 20 | MP0002064_seizures | 2.27391230 |
| 21 | MP0002272_abnormal_nervous_system | 2.23686893 |
| 22 | MP0000604_amyloidosis | 2.20485674 |
| 23 | MP0002638_abnormal_pupillary_reflex | 2.17479978 |
| 24 | MP0009745_abnormal_behavioral_response | 2.16308277 |
| 25 | MP0002419_abnormal_innate_immunity | 2.12091554 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.07046300 |
| 27 | MP0009046_muscle_twitch | 2.05464571 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.03905659 |
| 29 | MP0001984_abnormal_olfaction | 2.03101451 |
| 30 | MP0001986_abnormal_taste_sensitivity | 2.02560829 |
| 31 | MP0002063_abnormal_learning/memory/cond | 2.02308590 |
| 32 | MP0003195_calcinosis | 2.01964658 |
| 33 | MP0002572_abnormal_emotion/affect_behav | 2.01618885 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 2.01299872 |
| 35 | MP0000685_abnormal_immune_system | 2.00263453 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.99643343 |
| 37 | MP0003075_altered_response_to | 1.98900334 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.97931468 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.97253324 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.96684555 |
| 41 | MP0002693_abnormal_pancreas_physiology | 1.95994787 |
| 42 | MP0005025_abnormal_response_to | 1.94824938 |
| 43 | MP0009764_decreased_sensitivity_to | 1.90338488 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.89848119 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.89585247 |
| 46 | MP0002822_catalepsy | 1.88469250 |
| 47 | MP0001790_abnormal_immune_system | 1.87642215 |
| 48 | MP0005387_immune_system_phenotype | 1.87642215 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.87147306 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.83495279 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.80215423 |
| 52 | MP0000343_altered_response_to | 1.78116388 |
| 53 | MP0004885_abnormal_endolymph | 1.76709321 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.76612907 |
| 55 | MP0003122_maternal_imprinting | 1.70989987 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.65200725 |
| 57 | MP0001970_abnormal_pain_threshold | 1.64007716 |
| 58 | MP0002723_abnormal_immune_serum | 1.61449480 |
| 59 | MP0009278_abnormal_bone_marrow | 1.60373497 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.59489843 |
| 61 | MP0002736_abnormal_nociception_after | 1.58880655 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.57225045 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.56804221 |
| 64 | MP0001529_abnormal_vocalization | 1.55349858 |
| 65 | MP0003329_amyloid_beta_deposits | 1.54247997 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.53985996 |
| 67 | MP0003136_yellow_coat_color | 1.53981856 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.53573761 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.53170794 |
| 70 | MP0001486_abnormal_startle_reflex | 1.52454873 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.51221846 |
| 72 | MP0003879_abnormal_hair_cell | 1.50540629 |
| 73 | MP0004510_myositis | 1.50519280 |
| 74 | MP0001800_abnormal_humoral_immune | 1.50033144 |
| 75 | MP0003283_abnormal_digestive_organ | 1.47394667 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.45193641 |
| 77 | MP0002735_abnormal_chemical_nociception | 1.44332931 |
| 78 | * MP0003183_abnormal_peptide_metabolism | 1.43734145 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.43580911 |
| 80 | MP0001905_abnormal_dopamine_level | 1.39332406 |
| 81 | MP0001765_abnormal_ion_homeostasis | 1.37835055 |
| 82 | MP0002653_abnormal_ependyma_morphology | 1.37663572 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.37629933 |
| 84 | MP0008569_lethality_at_weaning | 1.36758779 |
| 85 | MP0004142_abnormal_muscle_tone | 1.35911738 |
| 86 | MP0002420_abnormal_adaptive_immunity | 1.34181900 |
| 87 | MP0008469_abnormal_protein_level | 1.33885627 |
| 88 | MP0001819_abnormal_immune_cell | 1.33772263 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.31860494 |
| 90 | MP0000678_abnormal_parathyroid_gland | 1.31411135 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.31276447 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 1.30898829 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.30442219 |
| 94 | MP0005365_abnormal_bile_salt | 1.30309415 |
| 95 | MP0002184_abnormal_innervation | 1.28456504 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 1.26843323 |
| 97 | MP0002229_neurodegeneration | 1.26663073 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 1.26633790 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 1.24509280 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 1.23288210 |
| 101 | MP0005058_abnormal_lysosome_morphology | 1.23072967 |
| 102 | MP0005253_abnormal_eye_physiology | 1.20769637 |
| 103 | MP0004924_abnormal_behavior | 1.17280994 |
| 104 | MP0005386_behavior/neurological_phenoty | 1.17280994 |
| 105 | MP0000955_abnormal_spinal_cord | 1.15326823 |
| 106 | MP0003172_abnormal_lysosome_physiology | 1.14847788 |
| 107 | MP0005166_decreased_susceptibility_to | 1.14838300 |
| 108 | MP0006292_abnormal_olfactory_placode | 1.13473457 |
| 109 | MP0001188_hyperpigmentation | 1.12759775 |
| 110 | MP0003633_abnormal_nervous_system | 1.12460040 |
| 111 | MP0002405_respiratory_system_inflammati | 1.11609601 |
| 112 | MP0000003_abnormal_adipose_tissue | 1.11573015 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 1.10421409 |
| 114 | MP0002254_reproductive_system_inflammat | 1.10213879 |
| 115 | MP0002882_abnormal_neuron_morphology | 1.10130756 |
| 116 | MP0003011_delayed_dark_adaptation | 1.09408145 |
| 117 | MP0001664_abnormal_digestion | 1.07066616 |
| 118 | MP0002066_abnormal_motor_capabilities/c | 1.06951437 |
| 119 | MP0003634_abnormal_glial_cell | 1.06483448 |
| 120 | MP0005535_abnormal_body_temperature | 1.05605931 |
| 121 | MP0003953_abnormal_hormone_level | 1.03969051 |
| 122 | MP0002933_joint_inflammation | 1.03289970 |
| 123 | MP0005595_abnormal_vascular_smooth | 1.03235589 |
| 124 | MP0000920_abnormal_myelination | 1.02454269 |
| 125 | MP0001663_abnormal_digestive_system | 1.01633949 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 1.00018134 |
| 127 | MP0000778_abnormal_nervous_system | 0.99741978 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.99712825 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.99381836 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.97575065 |
| 131 | MP0004811_abnormal_neuron_physiology | 0.95998141 |
| 132 | MP0005310_abnormal_salivary_gland | 0.93904897 |
| 133 | MP0004019_abnormal_vitamin_homeostasis | 0.93885903 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.93670780 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.93670780 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.93144238 |
| 137 | MP0005390_skeleton_phenotype | 0.92895779 |
| 138 | MP0004858_abnormal_nervous_system | 0.92871207 |
| 139 | MP0001542_abnormal_bone_strength | 0.91618468 |
| 140 | MP0001756_abnormal_urination | 0.90589243 |
| 141 | MP0002090_abnormal_vision | 0.90417411 |
| 142 | MP0004947_skin_inflammation | 0.88150933 |
| 143 | MP0009333_abnormal_splenocyte_physiolog | 0.87673515 |
| 144 | MP0004742_abnormal_vestibular_system | 0.87265670 |
| 145 | MP0003690_abnormal_glial_cell | 0.84856441 |
| 146 | MP0001963_abnormal_hearing_physiology | 0.84764533 |
| 147 | MP0005394_taste/olfaction_phenotype | 0.84702035 |
| 148 | MP0005499_abnormal_olfactory_system | 0.84702035 |
| 149 | MP0003868_abnormal_feces_composition | 0.83370774 |
| 150 | MP0005360_urolithiasis | 0.81295754 |
| 151 | MP0003631_nervous_system_phenotype | 0.80971917 |
| 152 | MP0000716_abnormal_immune_system | 0.80510452 |
| 153 | MP0003300_gastrointestinal_ulcer | 0.80157373 |
| 154 | MP0003279_aneurysm | 0.77239662 |
| 155 | MP0010329_abnormal_lipoprotein_level | 0.76613255 |
| 156 | MP0000681_abnormal_thyroid_gland | 0.76370174 |
| 157 | MP0001764_abnormal_homeostasis | 0.75916039 |
| 158 | MP0001873_stomach_inflammation | 0.75294059 |
| 159 | MP0005174_abnormal_tail_pigmentation | 0.75133411 |
| 160 | MP0008874_decreased_physiological_sensi | 0.75002670 |
| 161 | MP0005171_absent_coat_pigmentation | 0.74419917 |
| 162 | MP0003959_abnormal_lean_body | 0.74358815 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.72503755 |
| 164 | MP0004145_abnormal_muscle_electrophysio | 0.72228620 |
| 165 | MP0001853_heart_inflammation | 0.71461138 |
| 166 | MP0009643_abnormal_urine_homeostasis | 0.71070044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of glycolipid metabolism (HP:0010969) | 6.02129458 |
| 2 | * Abnormality of liposaccharide metabolism (HP:0010968) | 6.02129458 |
| 3 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.02129458 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.14760958 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.73699169 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.14214947 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.12489413 |
| 8 | Focal motor seizures (HP:0011153) | 3.88747006 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.84914379 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.69721934 |
| 11 | Decreased circulating renin level (HP:0003351) | 3.67906207 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.63631473 |
| 13 | Symptomatic seizures (HP:0011145) | 3.61854533 |
| 14 | Loss of speech (HP:0002371) | 3.53874892 |
| 15 | Mutism (HP:0002300) | 3.46190320 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.40488043 |
| 17 | Increased circulating renin level (HP:0000848) | 3.31019241 |
| 18 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.18754506 |
| 19 | Myositis (HP:0100614) | 3.16234005 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 3.14414194 |
| 21 | Visual hallucinations (HP:0002367) | 3.09297355 |
| 22 | Hypothermia (HP:0002045) | 3.09254849 |
| 23 | Atonic seizures (HP:0010819) | 3.04831697 |
| 24 | Mesangial abnormality (HP:0001966) | 3.02560441 |
| 25 | Orchitis (HP:0100796) | 3.00052098 |
| 26 | Ketoacidosis (HP:0001993) | 2.96423181 |
| 27 | Stomatitis (HP:0010280) | 2.91749125 |
| 28 | Eczematoid dermatitis (HP:0000976) | 2.85112445 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.84618725 |
| 30 | Optic neuritis (HP:0100653) | 2.84618725 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 2.82623238 |
| 32 | Epileptic encephalopathy (HP:0200134) | 2.80940916 |
| 33 | Agitation (HP:0000713) | 2.79604740 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.78447622 |
| 35 | Myokymia (HP:0002411) | 2.76095028 |
| 36 | Split foot (HP:0001839) | 2.75233642 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.74389403 |
| 38 | Pheochromocytoma (HP:0002666) | 2.74000067 |
| 39 | Hypokalemic alkalosis (HP:0001949) | 2.71222262 |
| 40 | Hyperaldosteronism (HP:0000859) | 2.68814717 |
| 41 | Axonal loss (HP:0003447) | 2.68624744 |
| 42 | Progressive neurologic deterioration (HP:0002344) | 2.68424233 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.68412245 |
| 44 | Increased serum ferritin (HP:0003281) | 2.68236448 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.66663678 |
| 46 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61315573 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.60686910 |
| 48 | * Dysostosis multiplex (HP:0000943) | 2.58731988 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.56593524 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.55798879 |
| 51 | Gout (HP:0001997) | 2.55459034 |
| 52 | Metabolic alkalosis (HP:0200114) | 2.54641327 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.54443562 |
| 54 | Disinhibition (HP:0000734) | 2.54393552 |
| 55 | Focal seizures (HP:0007359) | 2.53872981 |
| 56 | Glomerulonephritis (HP:0000099) | 2.53062981 |
| 57 | Absence seizures (HP:0002121) | 2.52538399 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.51739512 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49520265 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.49368796 |
| 61 | Hypokalemia (HP:0002900) | 2.48935460 |
| 62 | Dialeptic seizures (HP:0011146) | 2.48884056 |
| 63 | Hypomagnesemia (HP:0002917) | 2.48063007 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.47730373 |
| 65 | Anxiety (HP:0000739) | 2.47606054 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.45379902 |
| 67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45307549 |
| 68 | Complement deficiency (HP:0004431) | 2.44800242 |
| 69 | Gait imbalance (HP:0002141) | 2.44791815 |
| 70 | Purpura (HP:0000979) | 2.44664018 |
| 71 | Nuclear cataract (HP:0100018) | 2.43513868 |
| 72 | Retinal dysplasia (HP:0007973) | 2.41669283 |
| 73 | Abnormality of magnesium homeostasis (HP:0004921) | 2.38601080 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.38223831 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38223831 |
| 76 | Nephrogenic diabetes insipidus (HP:0009806) | 2.37304383 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.36434112 |
| 78 | Amyloidosis (HP:0011034) | 2.35366109 |
| 79 | Congenital primary aphakia (HP:0007707) | 2.34708467 |
| 80 | Hypsarrhythmia (HP:0002521) | 2.32770685 |
| 81 | Large for gestational age (HP:0001520) | 2.30085070 |
| 82 | Late onset (HP:0003584) | 2.30024045 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28505802 |
| 84 | Retinal atrophy (HP:0001105) | 2.28412831 |
| 85 | Polyphagia (HP:0002591) | 2.27986493 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27937898 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27937898 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27937898 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.27821558 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.27404142 |
| 91 | Generalized tonic-clonic seizures (HP:0002069) | 2.26352675 |
| 92 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.25055906 |
| 93 | Febrile seizures (HP:0002373) | 2.23759565 |
| 94 | Diplopia (HP:0000651) | 2.22967272 |
| 95 | Abnormality of binocular vision (HP:0011514) | 2.22967272 |
| 96 | Chronic bronchitis (HP:0004469) | 2.21212700 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19589872 |
| 98 | Obstructive lung disease (HP:0006536) | 2.19589872 |
| 99 | Abnormal drinking behavior (HP:0030082) | 2.18744135 |
| 100 | Polydipsia (HP:0001959) | 2.18744135 |
| 101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18497233 |
| 102 | Type II lissencephaly (HP:0007260) | 2.17395419 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.15255552 |
| 104 | Global brain atrophy (HP:0002283) | 2.14472870 |
| 105 | Xanthomatosis (HP:0000991) | 2.11002260 |
| 106 | Megalencephaly (HP:0001355) | 2.10244442 |
| 107 | Dementia (HP:0000726) | 2.09905861 |
| 108 | Restlessness (HP:0000711) | 2.09765291 |
| 109 | Hyperventilation (HP:0002883) | 2.09746790 |
| 110 | Hyperglycemia (HP:0003074) | 2.08982867 |
| 111 | Cortical visual impairment (HP:0100704) | 2.07971652 |
| 112 | Abnormal eating behavior (HP:0100738) | 2.07074432 |
| 113 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04888278 |
| 114 | Adrenal overactivity (HP:0002717) | 2.04597878 |
| 115 | Polyuria (HP:0000103) | 2.04138343 |
| 116 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03709234 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.03255560 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 2.02990675 |
| 119 | Hematochezia (HP:0002573) | 2.02880567 |
| 120 | Hemoptysis (HP:0002105) | 2.01073958 |
| 121 | Depression (HP:0000716) | 1.99618985 |
| 122 | J-shaped sella turcica (HP:0002680) | 1.98396211 |
| 123 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.98211383 |
| 124 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.98211383 |
| 125 | Pustule (HP:0200039) | 1.98021930 |
| 126 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97710753 |
| 127 | Menstrual irregularities (HP:0000858) | 1.96706568 |
| 128 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.95735798 |
| 129 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.95735798 |
| 130 | Abnormal protein glycosylation (HP:0012346) | 1.95735798 |
| 131 | Abnormal glycosylation (HP:0012345) | 1.95735798 |
| 132 | Abnormality of potassium homeostasis (HP:0011042) | 1.95657674 |
| 133 | Alkalosis (HP:0001948) | 1.94128743 |
| 134 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93942042 |
| 135 | Recurrent fungal infections (HP:0002841) | 1.93438580 |
| 136 | Acute necrotizing encephalopathy (HP:0006965) | 1.93240969 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.93238006 |
| 138 | Abnormality of chloride homeostasis (HP:0011422) | 1.92343210 |
| 139 | Hyperparathyroidism (HP:0000843) | 1.92007529 |
| 140 | Diminished motivation (HP:0000745) | 1.90155299 |
| 141 | Congenital stationary night blindness (HP:0007642) | 1.89051984 |
| 142 | Vaginal atresia (HP:0000148) | 1.88963285 |
| 143 | Abnormal urine output (HP:0012590) | 1.88591270 |
| 144 | Poor suck (HP:0002033) | 1.87802112 |
| 145 | Limb dystonia (HP:0002451) | 1.87307933 |
| 146 | Recurrent skin infections (HP:0001581) | 1.84473535 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.84200723 |
| 148 | Dysautonomia (HP:0002459) | 1.84105068 |
| 149 | Psychosis (HP:0000709) | 1.83167327 |
| 150 | Ankle clonus (HP:0011448) | 1.83152040 |
| 151 | Renal salt wasting (HP:0000127) | 1.82655544 |
| 152 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.82461637 |
| 153 | Genital tract atresia (HP:0001827) | 1.82430696 |
| 154 | Muscular hypotonia of the trunk (HP:0008936) | 1.82299928 |
| 155 | Petechiae (HP:0000967) | 1.82011355 |
| 156 | Abnormality of the fovea (HP:0000493) | 1.81063963 |
| 157 | Polyneuropathy (HP:0001271) | 1.77226088 |
| 158 | Abnormality of complement system (HP:0005339) | 1.77080964 |
| 159 | Cardiomegaly (HP:0001640) | 1.76902673 |
| 160 | Apathy (HP:0000741) | 1.75847722 |
| 161 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74621362 |
| 162 | Abnormality of the periventricular white matter (HP:0002518) | 1.73513516 |
| 163 | Albinism (HP:0001022) | 1.71838511 |
| 164 | Bone cyst (HP:0012062) | 1.71652003 |
| 165 | Keratoconjunctivitis (HP:0001096) | 1.70299827 |
| 166 | Keratoconjunctivitis sicca (HP:0001097) | 1.68747411 |
| 167 | Asymmetric septal hypertrophy (HP:0001670) | 1.66636303 |
| 168 | Hemiplegia (HP:0002301) | 1.65851848 |
| 169 | Meningitis (HP:0001287) | 1.64963568 |
| 170 | Thoracic kyphosis (HP:0002942) | 1.63940091 |
| 171 | * Joint stiffness (HP:0001387) | 1.62024726 |
| 172 | Opisthotonus (HP:0002179) | 1.60107324 |
| 173 | Hepatosplenomegaly (HP:0001433) | 1.59533456 |
| 174 | Ovoid vertebral bodies (HP:0003300) | 1.59240759 |
| 175 | Encephalitis (HP:0002383) | 1.59014224 |
| 176 | 3-Methylglutaconic aciduria (HP:0003535) | 1.58920209 |
| 177 | Increased CSF protein (HP:0002922) | 1.58476881 |
| 178 | Vasculitis (HP:0002633) | 1.58251906 |
| 179 | Increased IgM level (HP:0003496) | 1.57541392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.25301654 |
| 2 | MAPK15 | 4.16715074 |
| 3 | NTRK3 | 3.73538357 |
| 4 | MAP3K11 | 2.75681424 |
| 5 | TNIK | 2.63056947 |
| 6 | CASK | 2.61006010 |
| 7 | ARAF | 2.48039575 |
| 8 | WNK3 | 2.27830627 |
| 9 | MAP3K9 | 2.27130202 |
| 10 | EPHA4 | 2.20775979 |
| 11 | WNK4 | 2.18951934 |
| 12 | NME2 | 2.07287301 |
| 13 | TBK1 | 2.05010763 |
| 14 | MAP4K1 | 2.04384696 |
| 15 | BLK | 1.93994784 |
| 16 | PRKD3 | 1.92697410 |
| 17 | RIPK4 | 1.81028942 |
| 18 | CAMKK2 | 1.80526618 |
| 19 | MAP3K13 | 1.76066874 |
| 20 | IRAK4 | 1.74145738 |
| 21 | TXK | 1.73374120 |
| 22 | IKBKB | 1.71582115 |
| 23 | ABL2 | 1.68385315 |
| 24 | HIPK2 | 1.66584586 |
| 25 | UHMK1 | 1.66277933 |
| 26 | TNK2 | 1.62591759 |
| 27 | PASK | 1.60322967 |
| 28 | OXSR1 | 1.58144141 |
| 29 | MAP3K2 | 1.51707606 |
| 30 | STK16 | 1.51676948 |
| 31 | SGK223 | 1.50845559 |
| 32 | SGK494 | 1.50845559 |
| 33 | MAP2K7 | 1.50196900 |
| 34 | LIMK1 | 1.49749912 |
| 35 | NTRK1 | 1.46343503 |
| 36 | MAP2K6 | 1.45966307 |
| 37 | KIT | 1.45066979 |
| 38 | TESK2 | 1.44329918 |
| 39 | IKBKE | 1.44259912 |
| 40 | PIM2 | 1.43968695 |
| 41 | BRAF | 1.43533223 |
| 42 | MAP3K12 | 1.42710076 |
| 43 | IRAK1 | 1.41967005 |
| 44 | TYK2 | 1.41401672 |
| 45 | PRPF4B | 1.38150815 |
| 46 | TGFBR2 | 1.36855357 |
| 47 | MAP3K14 | 1.32996403 |
| 48 | ZAP70 | 1.32837737 |
| 49 | TLK1 | 1.32001430 |
| 50 | MARK1 | 1.29217377 |
| 51 | AKT3 | 1.27525231 |
| 52 | CAMK2B | 1.22056695 |
| 53 | NTRK2 | 1.21907671 |
| 54 | CDK19 | 1.21653407 |
| 55 | SYK | 1.17819011 |
| 56 | MAP2K3 | 1.16890066 |
| 57 | PRKCG | 1.15504486 |
| 58 | DDR2 | 1.14055034 |
| 59 | TESK1 | 1.13725341 |
| 60 | CDC42BPA | 1.13112452 |
| 61 | KSR2 | 1.11554946 |
| 62 | TAOK2 | 1.11520061 |
| 63 | MINK1 | 1.08573543 |
| 64 | CDK5 | 1.08561335 |
| 65 | GRK5 | 1.08232245 |
| 66 | MAP3K4 | 1.08046605 |
| 67 | MATK | 1.06243977 |
| 68 | IRAK2 | 1.03992316 |
| 69 | DAPK2 | 1.03719492 |
| 70 | NEK6 | 1.03592404 |
| 71 | TAOK1 | 1.02944721 |
| 72 | ACVR1B | 1.02606222 |
| 73 | MAP3K1 | 1.02011713 |
| 74 | MAPKAPK3 | 1.01764978 |
| 75 | CSK | 1.01754313 |
| 76 | PINK1 | 1.00004024 |
| 77 | CSF1R | 0.99243158 |
| 78 | GRK6 | 0.99175531 |
| 79 | MAP3K3 | 0.97082723 |
| 80 | MAPK13 | 0.95646607 |
| 81 | BCKDK | 0.94402581 |
| 82 | SGK2 | 0.92363901 |
| 83 | PRKCH | 0.88031425 |
| 84 | LYN | 0.87273250 |
| 85 | NME1 | 0.86297862 |
| 86 | PRKCE | 0.85742744 |
| 87 | TAOK3 | 0.85554327 |
| 88 | CAMK2A | 0.85229768 |
| 89 | STK39 | 0.84746460 |
| 90 | DYRK1A | 0.83836372 |
| 91 | MUSK | 0.83597604 |
| 92 | CAMK2D | 0.82564458 |
| 93 | BMPR1B | 0.82562081 |
| 94 | PAK6 | 0.81819504 |
| 95 | FGR | 0.80757712 |
| 96 | PRKD2 | 0.80589919 |
| 97 | JAK3 | 0.80091182 |
| 98 | STK38 | 0.80052787 |
| 99 | BMPR2 | 0.77839381 |
| 100 | PIK3CG | 0.77571178 |
| 101 | RIPK1 | 0.77077060 |
| 102 | CSNK1G2 | 0.75521953 |
| 103 | CDK3 | 0.75104896 |
| 104 | MAPK12 | 0.74622290 |
| 105 | TYRO3 | 0.74172817 |
| 106 | CAMK2G | 0.73584581 |
| 107 | HCK | 0.73473008 |
| 108 | MAP2K2 | 0.73276150 |
| 109 | MAP2K4 | 0.73266776 |
| 110 | LCK | 0.72273111 |
| 111 | FES | 0.67530855 |
| 112 | PAK3 | 0.67054016 |
| 113 | PKN1 | 0.66727398 |
| 114 | PRKG2 | 0.65445326 |
| 115 | ITK | 0.65380835 |
| 116 | BTK | 0.64455612 |
| 117 | KDR | 0.63394452 |
| 118 | DAPK1 | 0.63011187 |
| 119 | RPS6KA6 | 0.62016085 |
| 120 | CSNK1G3 | 0.61865995 |
| 121 | CHUK | 0.60392690 |
| 122 | IRAK3 | 0.59573454 |
| 123 | SIK2 | 0.59532312 |
| 124 | MAPKAPK5 | 0.59213872 |
| 125 | NLK | 0.58202613 |
| 126 | ADRBK2 | 0.58072824 |
| 127 | BCR | 0.56368315 |
| 128 | PHKG2 | 0.56298201 |
| 129 | PHKG1 | 0.56298201 |
| 130 | PDK1 | 0.55136886 |
| 131 | TIE1 | 0.53411613 |
| 132 | CAMKK1 | 0.53310413 |
| 133 | MARK3 | 0.53294379 |
| 134 | EPHA3 | 0.52991012 |
| 135 | GRK7 | 0.52757127 |
| 136 | VRK1 | 0.52623222 |
| 137 | EIF2AK3 | 0.52465457 |
| 138 | WNK1 | 0.52248900 |
| 139 | PRKCQ | 0.52007622 |
| 140 | RPS6KA2 | 0.50977994 |
| 141 | ERN1 | 0.50790382 |
| 142 | RAF1 | 0.50754871 |
| 143 | CDK14 | 0.50632437 |
| 144 | JAK2 | 0.50092701 |
| 145 | MARK2 | 0.50059253 |
| 146 | GRK1 | 0.49383182 |
| 147 | CSNK1A1L | 0.49261915 |
| 148 | RPS6KL1 | 0.49204094 |
| 149 | RPS6KC1 | 0.49204094 |
| 150 | MAPK7 | 0.48494771 |
| 151 | CSNK1A1 | 0.47938890 |
| 152 | PRKACA | 0.47011392 |
| 153 | FRK | 0.46248579 |
| 154 | CCNB1 | 0.45636324 |
| 155 | SCYL2 | 0.45605139 |
| 156 | PNCK | 0.45465025 |
| 157 | TSSK6 | 0.45147232 |
| 158 | CSNK1G1 | 0.44894912 |
| 159 | JAK1 | 0.43368079 |
| 160 | CAMK1 | 0.43198882 |
| 161 | MOS | 0.42279704 |
| 162 | MAPK4 | 0.42127799 |
| 163 | PTK2B | 0.42110181 |
| 164 | PDPK1 | 0.41820621 |
| 165 | ADRBK1 | 0.41094003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.72591418 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.02742779 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.85956955 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.81539548 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63338436 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.54005014 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.37540993 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.37417482 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.22358992 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18635712 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.17105470 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14615643 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.12814690 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06529621 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01008169 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96593685 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.94815399 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.93709299 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87271005 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.82935727 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82186758 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.80904893 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78520743 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77827277 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.67106916 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67098748 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.66244059 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59847861 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.59197271 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58195675 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57687424 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.56014094 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.55780520 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55495226 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.54651637 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.51813878 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.50762967 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.50359418 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47013117 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46783589 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46489570 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.45182978 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.40778323 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35930345 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34750473 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34344399 |
| 47 | * Lysosome_Homo sapiens_hsa04142 | 1.32597670 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31025974 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30985155 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30317675 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24322619 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21548693 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20109279 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18633131 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18319713 |
| 56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17882730 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17743507 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17616355 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15665220 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14198458 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 1.12531456 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10498404 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10285300 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09526087 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08059204 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06287926 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06010087 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05471093 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04873937 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04835579 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03626169 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02867323 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01545344 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99541430 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97139514 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96055522 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94932536 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94304073 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93734190 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.92794536 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.90438682 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88076330 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84471814 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.83803289 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82869983 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82734433 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.76935736 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76329393 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76308561 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75988898 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74565833 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71863178 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71032415 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70899265 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69673772 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69114863 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68469901 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66146689 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64591231 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63789192 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62793999 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.61052748 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60259271 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56181081 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55489039 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54565041 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54549978 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54075202 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53591676 |
| 110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53192644 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50795148 |
| 112 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50423376 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49924861 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48605461 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47533012 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47283603 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45755316 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45515518 |
| 119 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45272038 |
| 120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44441323 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44167149 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44151485 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44072985 |
| 124 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43980297 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43848419 |
| 126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43647827 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42471207 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42386079 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.42027889 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41868517 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40921387 |
| 132 | Gap junction_Homo sapiens_hsa04540 | 0.40768109 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39485077 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39012347 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38786642 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37920256 |
| 137 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37733279 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.36445414 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.35929089 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35349582 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35107306 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33952161 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30801481 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29440267 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.28114071 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.27705560 |
| 147 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27057263 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26471424 |
| 149 | Phagosome_Homo sapiens_hsa04145 | 0.25430075 |
| 150 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25236582 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24131031 |
| 152 | Peroxisome_Homo sapiens_hsa04146 | 0.22503314 |
| 153 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.22208895 |

